Skip to main content
. 2018 Aug 7;11:458. doi: 10.1186/s13071-018-3043-x

Table 2.

Mean acquired doses and months of flea/tick coverage in Spain over 12 months

12 week Fluralaner Monthly oral products Monthly spot-on products
Mean doses acquired ± SD* 1.6 ± 0.9a 3.2 ± 2.9b 2.9 ± 2.5c
Mean months of coverage ± SD* 4.3 ± 2.5a 3.2 ± 2.9b 2.9 ± 2.5c

*Different superscript letters indicate statistically significant differences at P < 0.05 (fluralaner versus monthly oral (t(8173) = 19.34. P < 0.0001) or monthly spot-on (t(24049) = 31.42, P < 0.0001)).